Literature DB >> 18282337

Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review.

N A Khalidi1, R Rebello, D D Robertson.   

Abstract

OBJECTIVES: We present a case of systemic lupus erythematosus with symptomatic sensorineural hearing loss which was successfully treated with azathioprine, as assessed both clinically and radiologically. We also present a review of the relevant literature. CASE REPORT: A woman with systemic lupus erythematosus presented with sensorineural hearing loss, initially on the right and subsequently developing on the left over several months. An audiogram revealed profound neurosensory hearing loss bilaterally. The patient was treated with prednisone 60 mg daily and azathioprine 200 mg daily. An improvement on the left was noted on follow-up audiography as well as on magnetic resonance imaging of the internal auditory canals and surrounding structures.
CONCLUSION: Sensorineural hearing loss has been described in autoimmune disorders but is rare. Aural symptoms have been described, with varying incidences (0-57.5 per cent), in systemic lupus erythematosus. However, symptomatic sensorineural hearing loss is rare in systemic lupus erythematosus. Prednisone appears essential when an immunological or vasculitic cause is found. The use of azathioprine should be considered, as well as follow-up with magnetic resonance imaging to detect improvement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282337     DOI: 10.1017/S0022215108001783

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  9 in total

1.  Detection of asymptomatic cranial neuropathies in patients with systemic lupus erythematosus and their relation to antiribosomal P antibody levels and disease activity.

Authors:  Wafaa Gaber; Yasser Ezzat; Neveen M El Fayoumy; Hanan Helmy; Abeer M Mohey
Journal:  Clin Rheumatol       Date:  2014-05-24       Impact factor: 2.980

Review 2.  Systemic Lupus Erythematosus and hearing disorders: Literature review and meta-analysis of clinical and temporal bone findings.

Authors:  A Di Stadio; Massimo Ralli
Journal:  J Int Med Res       Date:  2017-02-20       Impact factor: 1.671

3.  Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener's granulomatosis), or systemic lupus erythematosus.

Authors:  Torsten Rahne; Franziska Clauß; Stefan K Plontke; Gernot Keyßer
Journal:  Clin Rheumatol       Date:  2017-04-28       Impact factor: 2.980

Review 4.  Function of the audiovestibular system in children with systemic lupus erythematosus.

Authors:  Ghada Ibrahim Gad; Hanan Abdelateef
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

Review 5.  Audiovestibular Symptoms in Systemic Autoimmune Diseases.

Authors:  Massimo Ralli; Vittorio D'Aguanno; Arianna Di Stadio; Armando De Virgilio; Adelchi Croce; Lucia Longo; Antonio Greco; Marco de Vincentiis
Journal:  J Immunol Res       Date:  2018-08-19       Impact factor: 4.818

Review 6.  Sensorineural Hearing Loss in Sjögren's Syndrome.

Authors:  Yuko Okawa; Kenji Ihara
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

Review 7.  Bilateral sudden sensorineural hearing loss as a presenting feature of systemic lupus erythematosus: Case report and brief review of other published cases.

Authors:  Sylvain Chawki; Jessie Aouizerate; Selim Trad; Jacques Prinseau; Thomas Hanslik
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.

Authors:  Jose F Polanski; Eloise A Tanaka; Harymy Barros; Adriana G Chuchene; Patricia T G Miguel; Thelma L Skare
Journal:  Laryngoscope       Date:  2020-06-30       Impact factor: 2.970

Review 9.  Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment.

Authors:  Laura Girasoli; Diego Cazzador; Roberto Padoan; Ennio Nardello; Mara Felicetti; Elisabetta Zanoletti; Franco Schiavon; Roberto Bovo
Journal:  J Immunol Res       Date:  2018-09-26       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.